Tissue-Dependent Tumor Microenvironments and Their impact on immunotherapy Responses

被引:132
作者
Oliver, Amanda J. [1 ,2 ]
Lau, Peter K. H. [1 ,2 ]
Unsworth, Ashleigh S. [1 ,2 ]
Loi, Sherene [1 ,2 ]
Darcy, Phillip K. [1 ,2 ]
Kershaw, Michael H. [1 ,2 ]
Slaney, Clare Y. [1 ,2 ]
机构
[1] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
tumor microenvironment; tissue-specific microenvironment; immunotherapy; immunosuppression; anticancer therapy; T-CELLS; GENE-EXPRESSION; GROWTH-FACTOR; CANCER; MELANOMA; MACROPHAGES; METASTASIS; BLOCKADE; ENVIRONMENT; IMPROVES;
D O I
10.3389/fimmu.2018.00070
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recent advances in cancer immunology have led to a better understanding of the role of the tumor microenvironment (TME) in tumor initiation, progression, and metastasis. Tumors can occur at many locations within the body and coevolution between malignant tumor cells and non-malignant cells sculpts the TME at these sites. It has become increasingly clear that there are specific differences of the TMEs at different anatomical locations, and these tissue-specific TMEs regulate tumor growth, determine metastatic progression, and impact on the outcome of therapy responses. Herein, we review the scientific advances in understanding tissue-specific TMEs, discuss their impact on immunotherapeutic response, and assess the current clinical knowledge in this emerging field. A deeper understanding of the tissue-specific TME will help to develop effective immunotherapies against tumors and their metastases and assist in predicting clinical outcomes.
引用
收藏
页数:8
相关论文
共 79 条
[1]   Final Version of 2009 AJCC Melanoma Staging and Classification [J].
Balch, Charles M. ;
Gershenwald, Jeffrey E. ;
Soong, Seng-jaw ;
Thompson, John F. ;
Atkins, Michael B. ;
Byrd, David R. ;
Buzaid, Antonio C. ;
Cochran, Alistair J. ;
Coit, Daniel G. ;
Ding, Shouluan ;
Eggermont, Alexander M. ;
Flaherty, Keith T. ;
Gimotty, Phyllis A. ;
Kirkwood, John M. ;
McMasters, Kelly M. ;
Mihm, Martin C., Jr. ;
Morton, Donald L. ;
Ross, Merrick I. ;
Sober, Arthur J. ;
Sondak, Vernon K. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) :6199-6206
[2]   Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors [J].
Baluk, P ;
Morikawa, S ;
Haskell, A ;
Mancuso, M ;
McDonald, DM .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (05) :1801-1815
[3]   Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse [J].
Bates, Gaynor J. ;
Fox, Stephen B. ;
Han, Cheng ;
Leek, Russell D. ;
Garcia, Jose F. ;
Harris, Adrian L. ;
Banham, Alison H. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (34) :5373-5380
[4]   Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome [J].
Bergamaschi, A. ;
Tagliabue, E. ;
Sorlie, T. ;
Naurne, B. ;
Triulzi, T. ;
Orlandi, R. ;
Russnes, H. G. ;
Nesland, J. M. ;
Tammi, R. ;
Auvinen, P. ;
Kosma, V-M ;
Menard, S. ;
Borresen-Dale, A-L .
JOURNAL OF PATHOLOGY, 2008, 214 (03) :357-367
[5]   Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours [J].
Bialkowski, Lukasz ;
van Weijnen, Alexia ;
Van der Jeught, Kevin ;
Renmans, Dries ;
Daszkiewicz, Lidia ;
Heirman, Carlo ;
Stange, Geert ;
Breckpot, Karine ;
Aerts, Joeri L. ;
Thielemans, Kris .
SCIENTIFIC REPORTS, 2016, 6
[6]   Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy [J].
Brown, Christine E. ;
Alizadeh, Darya ;
Starr, Renate ;
Weng, Lihong ;
Wagner, Jamie R. ;
Naranjo, Araceli ;
Ostberg, Julie R. ;
Blanchard, M. Suzette ;
Kilpatrick, Julie ;
Simpson, Jennifer ;
Kurien, Anita ;
Priceman, Saul J. ;
Wang, Xiuli ;
Harshbarger, Todd L. ;
D'Apuzzo, Massimo ;
Ressler, Julie A. ;
Jensen, Michael C. ;
Barish, Michael E. ;
Chen, Mike ;
Portnow, Jana ;
Forman, Stephen J. ;
Badie, Behnam .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (26) :2561-2569
[7]   Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors [J].
Butler, Jason M. ;
Kobayashi, Hideki ;
Rafii, Shahin .
NATURE REVIEWS CANCER, 2010, 10 (02) :138-146
[8]   Patients with melanoma metastases at cutaneous and subcutaneous sites are highly susceptible to interleukin-2-based therapy [J].
Chang, E ;
Rosenberg, SA .
JOURNAL OF IMMUNOTHERAPY, 2001, 24 (01) :88-90
[9]   MUC4 mucin expression in human pancreatic tumours is affected by organ environment:: the possible role of TGFβ2 [J].
Choudhury, A ;
Moniaux, N ;
Ulrich, AB ;
Schmied, BM ;
Standop, J ;
Pour, PM ;
Gendler, SJ ;
Hollingsworth, MA ;
Aubert, JP ;
Batra, SK .
BRITISH JOURNAL OF CANCER, 2004, 90 (03) :657-664
[10]   Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer [J].
Cox, Thomas R. ;
Erler, Janine T. .
DISEASE MODELS & MECHANISMS, 2011, 4 (02) :165-178